Arcturus Skyrocketing in India?

Ignore the hype.

Daly Mail, 2023.04.12: “EXCLUSIVE: New Covid variant Arcturus is already in more than HALF of US states with California, New Jersey and Virginia emerging as hotspots — after strain sent infection rates skyrocketing in India”

Daily Record, 2023.04.12: “New 'Arcturus' Covid variant as surge of cases sees face mask rules return”:

OK, so let’s have a second opinion:

And that is all you need to know about the Surging Arcturus.

Just as 5 Eyes (and one nose in the form of Switzerland) in unison stopped reporting their cases completely since the last weekend, so that you won’t be able to compare to them in this latest “surge”:

France is sticking out like a sore thumb. Isn’t that odd? How come Macron didn’t get the message?

P.S. The comments section below just dug out collectively this additional fact:

https://ir.arcturusrx.com/news-releases/news-release-details/arcturus-announces-collaboration-csl-develop-and-commercialize :

Nov. 1, 2022: "Acrturus announced collaboration with CSL to develop and commercialize self-amplifying mRNA vaccines."

A 5′ cap (m7G) and poly A tail are common to all RNA transcripts. A Conventional mRNAs encode the vaccine immunogen and flanking 5′ and 3′ UTRs. An antigen or immunotherapy is translated from the nonreplicating transcript. B Self-amplifying RNA encodes 5′ and 3′ CSE sequences, the nsP1-4 genes, a subgenomic promoter, and the vaccine immunogen. Following in situ translation, the nsP1-4 proteins form an RdRP complex which recognizes flanking CSE sequences and amplifies vaccine-encoding transcripts. This results in an accumulation of the antigen or immunotherapy within the cell. C Trans-amplifying mRNAs use two different transcripts to achieve a similar effect to self-amplifying RNAs. A conventional mRNA encoding the nsP1-4 genes flanked by 5′ and 3′ UTRs is co-delivered with a separate transcript that encodes the viral CSE sequences, the subgenomic promoter, and the vaccine immunogen. In situ translation of the conventional mRNA results in the formation of the RdRP complex, which subsequently amplifies the vaccine-encoding transcript to result in the accumulation of the antigen or immunotherapy. UTR untranslated region, CSE conserved sequence elements, nsP1–4 nonstructural proteins 1–4, RdRP RNA-dependent RNA polymerase.